Sponsor pipeline

Forma Therapeutics, Inc. clinical trial pipeline

3 active trials 2 recruiting 1 Phase 3 1 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-13

Trial arms changed: 1 → 4

NCT06198712 A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients… · Phase 2

Phase 2		2
Phase 3		1

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT04624659	A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)	Sickle Cell Disease	Active, Not Recruiting	2026-04-06
Phase 2
NCT06198712	A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients…	Sickle Cell Disease	Recruiting	2026-08-12
NCT05953584	A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler…	Sickle Cell Disease	Recruiting	2025-09-18

Get alerts when Forma Therapeutics, Inc.'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.